High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy

Figure 4

Kaplan–Meier curves showing overall survival (OS) after starting ADT with androgen receptor targeting therapy (ART) (a) or docetaxel (b) as the first-line CRPC treatment, comparing an ALP flare ratio at 1 month less than 1.57 and 1.57 or more (a) and less than 1.90 and 1.90 or more (b).

(a)

(b)